CD274 and neoplasm: In general, tumor foreignness, patient health status, other inhibitory processes within the tumor, functional exhaustion of tumor-infiltrating lymphocytes, and the sensitivity of tumor cells to tumor-specific T cells may affect the outcome of PD-1/PD-L1 blockade.